Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.499,20
-0,62%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TScan Therapeutics Inc (TCRX) TScan Therapeutics Inc (TCRX) Notizie

TScan Therapeutics Inc

TCRX
8,56
-0,09 (-1,04%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202422:05GLOBETScan Therapeutics Announces Upcoming Presentations at the..
24/4/202417:03GLOBETScan Therapeutics Announces Exercise of Underwriters'..
22/4/202423:01GLOBETScan Therapeutics Announces Upcoming Presentations at the..
19/4/202416:05GLOBETScan Therapeutics Announces Closing of Upsized Public..
17/4/202406:30GLOBETScan Therapeutics Announces Pricing of Upsized $150 Million..
16/4/202422:25GLOBETScan Therapeutics Announces Launch of $125 Million Proposed..
16/4/202422:01GLOBETScan Therapeutics Provides Clinical Pipeline Update and..
08/4/202414:00GLOBETScan Therapeutics Appoints Seasoned Hematology and Oncology..
02/4/202413:00GLOBETScan Therapeutics Announces Upcoming Presentation at the..
06/3/202422:11EDGAR2Form S-3 - Registration statement under Securities Act of..
06/3/202422:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202413:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202413:15EDGAR2Form 8-K - Current report
14/2/202422:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202413:15EDGAR2Form 8-K - Current report
11/12/202314:00EDGAR2Form 8-K - Current report
07/12/202313:15EDGAR2Form 8-K - Current report
09/11/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:15EDGAR2Form 8-K - Current report
29/8/202314:02DJNTScan Gets FDA Clearance of Investigational New Drug..
10/8/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:15EDGAR2Form 8-K - Current report
25/7/202301:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202301:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/6/202314:30EDGAR2Form 8-K - Current report
06/6/202316:25DJNTScan Therapeutics Shares Rise 17% After FDA Clears IND for..
26/5/202301:50DJNStocks to Watch: Marvell Technology, Workday, Gap, TScan..
09/5/202316:08DJNTScan Therapeutics Shares Take Flight on Amgen Pact
09/5/202315:48DJNAmgen, TScan Therapeutics Set Crohn's Disease Collaboration
Apertura: 8,79 Min: 8,55 Max: 9,09
Chiusura: 8,65

La tua Cronologia

NASDAQ
TCRX
TScan Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network